Department of Paediatrics, Infectious Diseases Unit, Regina Margherita Children's Hospital, University of Turin, Piazza Polonia, 94, 10126, Turin, TO, Italy.
Microbiology and Virology Unit, AOU Città Della Salute e Della Scienza di Torino, Turin, Italy.
Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1727-1735. doi: 10.1007/s10096-021-04222-5. Epub 2021 Mar 20.
Antimicrobial resistance is one of the most relevant threats in public health worldwide. Strategies as antimicrobial stewardship programs, aiming to preserve our antibiotic armamentarium, have been implemented since 2007 in adult and paediatric patients. We aim to describe the first experience of a paediatric antimicrobial stewardship program. We conducted a retrospective observational study in a tertiary care children's hospital. A team composed of a microbiologist, an infectious diseases physician, and a paediatrician led the project. All positive blood and cerebrospinal fluid cultures and other biological samples yielding multi-drug-resistant bacteria were collected and reviewed through a prospective-audit-with-feedback strategy. We recorded patient characteristics and worth monitoring prescribed antibiotics. The antimicrobial stewardship audit could end in intervention (step-up/step-down and broadening/narrowing) or recommendation(s). We then checked out wards staff compliance. The team performed 192 interventions out of 584 reviews, mostly suggesting discontinuation of antibiotics (in 76.0% of cases and 39.7% of running molecules). The antibiotic spectrum was more likely tapered than expanded (p < 0.0001), and we ordered more narrow-spectrum antibiotic molecules than local medical staff straightaway did (p = 0.0113). Interventions were most likely needed in case of documented infections (p < 0.0001) and in surgical patients (p = 0.0002). In 85.9% of interventions, ward teams fully agreed with our argument. This study demonstrated an antimicrobial stewardship program to be a suitable method for improving the appropriateness of antimicrobial use in hospitalized children.
抗微生物药物耐药性是全球公共卫生领域最相关的威胁之一。自 2007 年以来,一直针对成人和儿科患者实施旨在保护我们抗生素武器库的抗微生物药物管理策略。我们旨在描述儿科抗微生物药物管理计划的首次经验。我们在一家三级保健儿童医院进行了回顾性观察性研究。一个由微生物学家、传染病医生和儿科医生组成的团队领导了该项目。所有阳性血液和脑脊液培养物以及其他产生多药耐药菌的生物样本均通过前瞻性审核-反馈策略进行收集和审查。我们记录了患者特征和值得监测的处方抗生素。抗微生物药物管理审核可能会进行干预(升级/降级和拓宽/变窄)或提出建议。然后,我们检查了病房工作人员的遵守情况。该团队在 584 次审查中进行了 192 次干预,主要建议停止使用抗生素(在 76.0%的情况下和 39.7%的正在使用的分子)。抗生素谱更有可能变窄而不是扩大(p < 0.0001),并且我们开出的窄谱抗生素分子比当地医务人员直接开出的更窄(p = 0.0113)。如果有记录的感染(p < 0.0001)和手术患者(p = 0.0002),则最需要进行干预。在 85.9%的干预中,病房团队完全同意我们的观点。这项研究表明,抗微生物药物管理计划是一种合适的方法,可以提高住院儿童中抗微生物药物使用的适当性。